195.49 Cr
1.08%
MSCI ACWI TRI
INF754K01LS1
100.0
100.0
100
Mr. Bhavesh Jain, Ms. Manasi Jalgaonkar & Mr. Amit Vora
| Fund Performance | 1Y (%) | 3Y (%) | 5Y (%) |
|---|---|---|---|
| Edelweiss MSCI India Domestic & World Healthcare 45 Index Fund - Regular Plan - IDCW Option | 10.75 | 15.44 | 11.39 |
| MSCI ACWI TRI | 32.81 | 24.87 | 15.16 |
Equity
Debt
Others
The Scheme will invest in stocks comprising of the MSCI India Domestic IMI and World Healthcare Select Index with the objective to provide investment returns that, before expenses, closely corresponds to the returns equivalent to the index, subject to tracking errors. However, there is no assurance that the investment objective of the Scheme will be realized and the Scheme does not assure or guarantee any returns.
| Company | Holdings (%) |
|---|---|
| SUN PHARMACEUTICAL INDUSTRIES LTD. EQ NEW F.V. RE.1/- | 10.96 |
| Eli Lilly & Co | 6.85 |
| APOLLO HOSPITALS ENTERPRISE LIMITED EQ NEW F.V. RS.5/- | 5.71 |
| MAX HEALTHCARE INSTITUTE LIMITED EQ | 5.21 |
| DIVIS LABORATORIES LIMITED EQ NEW RS. 2/- | 5.14 |
| CIPLA LIMITED EQ NEW FV RS.2/- | 4.84 |
| Dr. Reddys Laboratories Ltd | 4.44 |
| JOHNSON & JOHNSON | 4.35 |
| LUPIN LIMITED EQ NEW F.V. RS.2/- | 3.62 |
| LAURUS LABS LIMITED EQ NEW FV RS. 2/- | 3.48 |
| Sector | Holdings (%) |
|---|---|
| Healthcare | 69.3 |